Doha Declaration: Compulsory Licensing and Access to Drugs

Doha Declaration: Compulsory Licensing and Access to Drugs

Ms. Kiran Kumari

Contact

Dr. Ajay Sharma

Contact

Doha Declaration: Compulsory Licensing and Access to Drugs

Article Fingerprint

ReserarchID

PDDTMCRF3K

Doha Declaration: Compulsory Licensing and Access to Drugs Banner

AI TAKEAWAY

Connecting with the Eternal Ground

Abstract

This paper analyses compulsory licensing evolution phases and sheds light on reasons behind development especially after trade related aspects of intellectual property rights (TRIPS) provisions. Without patents, the innovators can neither be adequately compensated for their costs of research nor be encouraged for further research to develop new and improved products. Patent protection is therefore accepted as a necessary evil, despite its conflict with the competitions laws and human rights law (in case of pharmaceutical patents). Prior to Doha declaration pharmaceutical companies were enjoying the monopoly right because of patent protection regime for manufacturing, sale, and import the products which result into high cost of the patented products. Doha Conference on November 14, 2001 forced many countries to amend their patent rights for the purpose of compulsory licensing. This increased cost on patented molecules was a major hindrance for access to medicine. Public health officials considered Doha Declaration on compulsory licensing a positive approach in prioritizing public health over intellectual property rights.

References

21 Cites in Article

Reference Format

Rumman Ahmed,Amol Sharma (2012). Novartis Fights India for Cancer Pill Patent.
H Bale (1998). The conflicts between parallel trade and product access and innovation: The case of pharmaceuticals.
(2014). EUP referees 1 November 2012–31 July 2014.
Nilima Chandiramani (2002). THE ECONOMIC ORDER.
Harish Chander,Vaibhav Choudhary,Vikas Kumar (2013). Current Scenario of Patent Act: Compulsory Licensing.
K Christensen (2012). Gray Markets, Forbes India.
David Cutler (2017). Empirical and Mathematical Reasoning: The Business and Politics of Health.
E,Durojaye (2011). COMPULSORY LICENSING AND ACCESS TO MEDICINES IN POST DOHA ERA: WHAT HOPE FOR AFRICA?.
R Gupta (2010). Compulsory Licensing under TRIPS: How afar it Addresses Public Health Concerns in Developing Nations.
T Jain (2009). Compulsory licenses under trips and its obligations for member countries.
A Kaur,R Chaturvedi (2015). Compulsory Licensing of Drugs and Pharmaceuticals: Issues and Dilemma.
K Kulkarni,S Mohanti (2013). Unknown Title.
S Kumar (2013). Unknown Title.
V Mathur,B Nagori,M Tiwari (2016). Compulsory Licensing of Pharmaceutical Patents in India: A Research Study.
Madras High,Court Judgement (2017). Trotter, Sir Victor Murray Coutts, (12 May 1874–12 May 1929), Chief Justice of the High Court of Madras since 1924; Puisne Judge, 1915–24.
P Narayanan (1998). Patent Law.
R Ayyangar (1959). Decision on Timing of Patent Revision.
S Rana (2018). November 2018 news from ICER.
L Taylor (2013). Novartis loses Indian Glivec patent case.
(2001). World Trade Organization (WTO) - Doha Ministerial 2001: Declaration on the Trips Agreement and Public Health.
D Yang (2012). Compulsory licensing: For better or for worse, the done deal lies in the balance.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Ms. Kiran Kumari. 2019. \u201cDoha Declaration: Compulsory Licensing and Access to Drugs\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 19 (GJMR Volume 19 Issue B1).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 19 Issue B1

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-B Classification NLMC Code: QV 4

Submission ReceivedDecember 6, 2018
Peer Review Double Blind
Handling Editor
Accepted January 1, 2019
Published January 15, 2019

Version of record

v1.2

Issue date

April 8, 2019

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Score: 107

Country: India

Subject: Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine

Authors: Ms. Kiran Kumari, Dr. Ajay Sharma (PhD/Dr. count: 1)

View Count (all-time): 208

Total Views (Real + Logic): 2844

Total Downloads (simulated): 1459

Publish Date: 2019 04, Mon

Monthly Totals (Real + Logic):

Month 1: 38 views
Month 2: 42 views
Month 3: 37 views
Month 4: 29 views
Month 5: 36 views
Month 6: 40 views
Month 7: 32 views
Month 8: 41 views
Month 9: 57 views
Month 10: 56 views
Month 11: 26 views
Month 12: 42 views
Month 13: 38 views
Month 14: 28 views
Month 15: 43 views
Month 16: 31 views
Month 17: 43 views
Month 18: 23 views
Month 19: 30 views
Month 20: 32 views
Month 21: 22 views
Month 22: 22 views
Month 23: 32 views
Month 24: 36 views
Month 25: 38 views
Month 26: 40 views
Month 27: 26 views
Month 28: 16 views
Month 29: 45 views
Month 30: 11 views
Month 31: 14 views
Month 32: 38 views
Month 33: 30 views
Month 34: 19 views
Month 35: 22 views
Month 36: 28 views
Month 37: 33 views
Month 38: 15 views
Month 39: 17 views
Month 40: 27 views
Month 41: 22 views
Month 42: 12 views
Month 43: 23 views
Month 44: 41 views
Month 45: 24 views
Month 46: 22 views
Month 47: 24 views
Month 48: 30 views
Month 49: 39 views
Month 50: 39 views
Month 51: 24 views
Month 52: 44 views
Month 53: 44 views
Month 54: 39 views
Month 55: 25 views
Month 56: 37 views
Month 57: 31 views
Month 58: 35 views
Month 59: 15 views
Month 60: 39 views
Month 61: 38 views
Month 62: 30 views
Month 63: 21 views
Month 64: 18 views
Month 65: 17 views
Month 66: 39 views
Month 67: 20 views
Month 68: 33 views
Month 69: 17 views
Month 70: 37 views
Month 71: 28 views
Month 72: 14 views
Month 73: 40 views
Month 74: 42 views
Month 75: 37 views
Month 76: 33 views
Month 77: 37 views
Month 78: 28 views
Month 79: 37 views
Month 80: 45 views
Month 81: 32 views
Month 82: 39 views
Month 83: 28 views
Month 84: 45 views
Month 85: 50 views

Total Views: 2844

Total Downloads: 1459

2026 Trends

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]